Clinical Trial Update: Pharmacogenetics Informed Tricyclic Antidepressant Dosing (PITA) [Phase 4]

View source ↗

Summary

Phase 4 trial update for pharmacogenetics-informed dosing of tricyclic antidepressants in major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Radboud University Medical Center | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED